COVID-19 IgM/IgG

Rapid Diagnostics Test kits (RDT)

COVID-19 IgM/IgG

Chromatographic immunoassay kit for rapid, qualitative detection of Covid-19 (SARS-CoV-2) antibody from blood specimens ,2 cassette

6f8106912464aecd016193e2c4fdafa4_1708329981_63.png





Product features
  • MFDS approval
  • CE mark
  • Getting results In 20 minutes
  • Simple and easy to use
  • Optimized for Point of Care with a small diagnostic kit 
  • No need to use extra reader
  • High diagnostic accuracy
  • Economical and capable of mass testing
  •  Specification

    Specimen Whope blood, Serum and Plasma
    Specimen volume 100㎕
    Test time 15 minutes
    Storage temperature 2-30℃
    Expiration date Refer to label for expiration date



  • COVID-19 disease caused by the SARS-CoV-2 virus was declared "pandemic" by the World Health Organization (WHO) in March 2020 as a new respiratory epidemic. Symptoms of this epidemic vary, but are mainly fatigue, high fever, and cough, and in more severe cases, breathing problems and severe lung damage. Although molecular diagnostics are the standard diagnostic method for COVID-19, rapid antigen testing, which is easy to use, convenient, and field-ready, has been introduced and widely used for quarantine in many developed countries, including the United States, Japan, and Europe.